PSD4 and invasive ductal breast carcinoma: To assess in vivo the impact of the loss of EFA6B, we have used the MCF10DCIS.com xenograft model that recapitulates the transition from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC)32.